For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
What Trump’s vaccine executive order actually does
Yesterday, President Trump signed an executive order directing federal health agencies to revise childhood vaccine recommendations, reducing the number of vaccines recommended for…
Blog
Trump administration decision highlights disastrous Part D redesign
The Trump administration recently announced the end of a demonstration project that was pulled together by the Biden administration as the Inflation Reduction…
Search Posts
The New York Post
Stop panicking about ‘Delta’: Vaccines are effective against ALL strains of COVID
Delta is coming. But contrary to alarmists at home and abroad, there is little reason to panic. Scientists first identified the Delta variant…
Blog
End Useless Vaccination of the Immune
Six months ago, as the first vaccines were becoming available, I wrote, “Why Are We Vaccinating People Who Have Recovered From COVID-19?” Now…
Real Clear Policy
Risk, Trust, and COVID
When the Centers for Disease Control and Prevention announced last month that vaccinated people need not wear masks regularly, Americans’ reaction was polarized. Many…
City Journal
Obamacare Survives a Third (and Likely Final) Challenge
The Supreme Court has now ruled on three legal challenges to the Affordable Care Act, and for opponents of the statute the third time…
Blog
Exposed: Bloomberg’s Anti-Tobacco Meddling in Developing Countries
Back in February I wrote a piece for Inside Sources titled “Bloomberg’s Philanthro-Colonialism: A Threat to Global Health and Science,” criticizing the behavior…
Blog
It’s up to Drug Reformers to Stop the War on Nicotine
In recent years, a growing number of Americans have been waking up to the failure of the War on Drugs. Officially initiated by…